Health One Merger
Signalife to merge with Health One, creating the world's only electronic health record centered around the human heart and surrounding cardiovascular database. The Board has approved the merger, and formed pursuit teams to consummate the multi-cultural, multi-lingual, worldwide business combination. Please continue to monitor this site and the public filings for important details. No shareholder that is unable to prove truthful shareholder status, free from fraud, will be able to exchange his shares for the common and preferred stock to be issued. The exchange will increase all legitimate shareholder's equity amount in the surviving entity. Carefully following the website and the public filings will assure that all real shareholders are fully protected and provided for.







I am very impressed with the superb quality of the Signalife signal as you so clearly demonstrate. I foresee that your technology will revolutionize the industry because there is nothing on the horizon that approaches your accuracy.
- Robert E. Windom,
  M.D., FACP, FACC


The spectrum of technology presented by Signalife exceeds by magnitudes all existing systems. Fidelity 100 is the "Grail" of ambulatory EKG monitoring that I have been seeking for nearly 40 years.
- Steven J. Phillips, MD


The Signalife, Fidelity 100 is the most advanced technology in ECG monitoring available today. The ability of the Fidelity 100 to capture clean ECG tracings in an active, ambulatory setting will greatly enhance our ability to detect cardiac disease early and will lead to life-saving intervention.
- Jay A. Johnson, MD


 
Signalife, Inc. is a research and development life sciences company currently launching a breakthrough ECG (electrocardiography) monitoring system. Fidelity 100 will allow for the first time, real-time ambulatory 12-lead heart patient monitoring via their clinically superior system for the recording of a high-quality ECG never seen before in the clinical setting.

Signalife’s patented technology provides a unique platform for biomedical signal acquisition, classification and evaluation for treatment of cardiovascular diseases. The technology has many applications for use ranging from surgically invasive procedures to noninvasive procedures.

  
Signalife’s technology is building a new era in cardiac monitoring. Our breakthrough technology addresses one of the most challenging areas of ECG recordings. It provides a high fidelity signal in an ambulatory environment and during surgery. Clear data is the foundation for a physician’s interpretation and accurate diagnosis.

Our Fidelity 100 12-lead heart monitoring system includes a patient module that wirelessly transmits the ECG to a data collection device (laptop) which can store up to 2500 hours of data. During patient examination or surgery, a physician can mark events of interest for future evaluation.

  

Copyright © 2008 Signalife, Inc. All Rights Reserved. Signalife and the Signalife logo are trademarks and service marks owned by Signalife, Inc.
No part of this site may be used without the express permission of the copyright holder.
Terms & Conditions